Seeing Is Believing
Currently out of the existing stock ratings of Louise Chen, 376 are a BUY (88.89%), 43 are a HOLD (10.17%), 4 are a SELL (0.95%).
Analyst Louise Chen works at CANTOR FITZGERALD with a stock forecast success ratio of 38.57% fulfilled within 180.36 days on average.
Louise Chen’s has documented 818 price targets and ratings displayed on 56 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CDTX, Cidara Therapeutics at 23-Apr-2024.
Analyst best performing recommendations are on HZNP (HORIZON PHARMA PLC).
The best stock recommendation documented was for HZNP (HORIZON PHARMA PLC) at 2/27/2019. The price target of $26 was fulfilled within 1 day with a profit of $4.15 (18.99%) receiving and performance score of 189.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
3 months 7 days ago
0/5 (0%)
$34.34 (396.54%)
Hold
3 months 18 days ago
0/2 (0%)
$21.59 (291.36%)
Hold
1.5
3 months 19 days ago
0/4 (0%)
$0.49 (48.51%)
Hold
1
$-0.17 (-14.53%)
2
4 months 11 days ago
1/4 (25%)
$0.06 (6.38%)
1
Hold
38
5 months 15 days ago
0/7 (0%)
$23.92 (169.89%)
Which stock is Louise Chen is most bullish on?
Which stock is Louise Chen is most reserved on?
What Year was the first public recommendation made by Louise Chen?